Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease

Annals of Neurology

Volumn 68, Issue 6, 2010, Pages 865-875

  Quiroz, Yakeel T ^a,b   Budson, Andrew E ^c,d   Celone, Kim ^a   Ruiz, Adriana ^b   Newmark, Randall ^a   Castrillõn, Gabriel ^e   Lopera, Francisco ^b   Stern, Chantal E ^a  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSIDAD DE ANTIOQUIA   (Colombia)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Instituto de Alta Tecnología Médica de Antioquia IATM   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

PRESENILIN 1;

ADULT; ALZHEIMER DISEASE; ARTICLE; ASSOCIATIVE MEMORY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; EPISODIC MEMORY; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; MALE; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; TASK PERFORMANCE;

ADULT; ALZHEIMER DISEASE; ASSOCIATION LEARNING; BRAIN MAPPING; DISEASE PROGRESSION; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TESTS; OXYGEN; PRESENILIN-1; RECOGNITION (PSYCHOLOGY); YOUNG ADULT;

EID: 78650911252     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22105     Document Type: Article

References (46)

1. Alzheimer's Association. Early onset dementia: a national challenge, a future crisis. Alzheimer's Association, 2006. Available at: http://www.alz.org/ national/documents/report-earlyonset-summary.pdf. Accessed July 18, 2010.
2. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-706. (Pubitemid 21912142)
3. Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 18: 973-977.
4. Alzheimer's Disease Collaborative Group. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet 1995; 11: 219-222.
5. Lopera F, Ardilla A, Martínez A, et al. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 1997; 277: 793-799.
6. Arango-Lasprilla JC, Iglesias J, Lopera F., Neuropsychological study of familial Alzheimer's disease caused by mutation E280A in the presenilin 1 gene. Am J Alzheimers Dis Other Demen 2003; 18: 137-146.
7. Bobes MA, García YF, Lopera F, et al. ERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280A PS-1 mutation. Hum Brain Mapp 2010; 31: 247-265.
8. Gõmez-Isla T, Wasco W, Pettingell WP, et al. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes. Ann Neurol 1997; 41: 809-813.
9. Ardila A, Lopera F, Rosselli M, et al. Neuropsychological profile of a large kindred with familial Alzheimer's disease caused by the E280A single presenilin-1 mutation. Arch Clin Neuropsychol 2000; 15: 515-528.
10. Rosselli MC, Ardila AC, Moreno SC, et al. Cognitive decline in patients with familial Alzheimer's disease associated with E280A presenilin-1 mutation: a longitudinal study. J Clin Exp Neuropsychol 2000; 22: 483-495.
11. Petersen RC, Smith GE, Ivnik RJ, et al. Memory function in very early Alzheimer's disease. Neurology 1994; 44: 867-872.
12. Gainotti G, Marra C, Villa G, et al. Sensitivity and specificity of some neuropsychological markers of Alzheimer dementia. Alzheimer Dis Assoc Disord 1998; 12: 152-162.
13. Remy F, Mirrashed F, Campbell B, Richter W,. Verbal episodic memory impairment in Alzheimer's disease: a combined structural and functional MRI study Neuroimage 2005; 25: 253-266.
14. Kordower, JH, Chu YP, Stebbins GT, et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001; 49: 202-213.
15. Sperling RA, Bates JF, Chua EF, et al. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003; 74: 44-50.
16. Celone K, Calhoun VD, Dickerson BC, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. J Neurosci 2006; 26: 10222-10231.
17. Dickerson BC, Sperling RA,. Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging. Behav Neurol 2009; 21: 63-75.
18. Dickerson BC, Salat D, Bates J, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004; 56: 27-35.
19. Nestor PJ, Scheltens P, Hodges JR,. Advances in the early detection of Alzheimer's disease (Review). Nat Med 2004; 10: S34-S41.
20. Machulda MM, Ward HA, Borowski B, et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients. Neurology 2003; 61: 500-506.
21. Petrella JR, Krishnan S, Slavin MJ, et al. Mild cognitive impairment: evaluation with 4-T functional MR imaging. Radiology 2006; 240: 177-186.
22. Dickerson BC, Salat DH, Greve DN, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 2005; 65: 404-411.
23. Hämäläinen A, Pihlajamäki M, Tanila H, et al. Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol Aging 2007; 28: 1889-1903.
24. Bookheimer SY, Strojwas MH, Cohen MS, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000; 343: 450-456.
25. Mondadori CR, Buchmann A, Mustovic H, et al. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain 2006; 129: 2908-2922.
26. Lendon CL, Martinez A, Behrens IM, et al. E280A PS1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles. Hum Mutat 1997; 10: 186-195.
27. Aguirre-Acevedo DC, Gõmez RD, Moreno S, et al. [Validity and reliability of the CERAD-Col neuropsychological battery]. Rev Neurol 2007; 45: 655-660. [Spanish].
28. Sperling RA, Bates JF, Cocchiarella AJ, et al. Encoding novel face name associations: a functional MRI study. Hum Brain Mapp 2001; 14: 129-139.
29. Freire L, Roche A, Mangin J-Fr,. What is the best similarity measure for motion correction in fMRI? IEEE Trans Med Imaging 2002; 21: 470-484.
30. Ashburner J,. A fast diffeomorphic image registration algorithm. Neuroimage 2007; 38: 95-113.
31. Trivedi MA, Schmitz TW, Ries ML, et al. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study. BMC Med 2006; 4: 1.
32. Dickerson BC, Miller SL, Greve DN, et al. Prefrontal-hippocampal-fusiform activity during encoding predicts intraindividual differences in free recall ability: an event-related functional-anatomic MRI study. Hippocampus 2007; 17: 1060-1070.
33. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH,. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003; 19: 1233-1239.
34. Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 2006; 31: 1116-1128.
35. Pruessner JC, Li LM, Serles W, et al. Volumetry of hippocampus and amygdala with high-resolution MRI and three dimensional analysis software: minimizing the discrepancies between laboratories. Cerebral Cortex 2000; 10: 433-442.
36. Duvernoy HM,. The human hippocampus, functional anatomy, vascularization and serial sections with MRI. 3rd ed. Springer, 2005.
37. Braak H, Braak E,. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995; 16: 271-278.
38. Stern CE, Sherman SJ, Kirchhoff BA, Hasselmo ME,. Medial temporal and prefrontal contributions to working memory tasks with novel and familiar stimuli. Hippocampus 2001; 11: 337-346.
39. Schon K, Hasselmo ME, LoPresti ML, et al. Persistence of parahippocampal representation in the absence of stimulus input enhances long-term encoding: a functional magnetic resonance imaging study of subsequent memory after a delayed match-to-sample task. J Neurosci 2004; 24: 11088-11097.
40. Gonsalves BD, Kahn I, Curran T, et al. Memory strength and repetition suppression: multimodal imaging of medial temporal cortical contributions to recognition. Neuron 2005; 47: 751-761.
41. Otten LJ, Henson RN, Rugg MD,. Depth of processing effects on neural correlates of memory encoding: relationship between findings from across- and within-task comparisons. Brain 2001; 124: 399-412.
42. Yu JT, Chang RC, Tan L,. Calcium dysregulation in Alzheimer's disease: From mechanisms to therapeutic opportunities. (Review). Prog Neurobiol 2009; 89: 240-255.
43. Smith IF, Green KN, LaFerla FM,. Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Cell Calcium 2005; 38: 427-437.
44. Saitoh T, Horsburgh K, Masliah E,. Hyperactivation of signal transduction systems in Alzheimer's disease. Ann N Y Acad Sci 1993; 695: 34-41.
45. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M,. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009; 457: 981-989.
46. Hasselmo ME,. A computational model of the progression of Alzheimer's disease. MD Comput 1997; 14: 181-189.